# The Effectiveness of Hemopatch® in the Reduction of Post-surgical Serous Drainage

> **NCT04904653** · PHASE4 · UNKNOWN · sponsor: **Instituto de Investigación Hospital Universitario La Paz** · enrollment: 118 (estimated)

## Conditions studied

- Hemopatch
- Breast Cancer
- Axillary Lymphadenectomy

## Interventions

- **DEVICE:** Hemopatch
- **OTHER:** Control group

## Key facts

- **NCT ID:** NCT04904653
- **Lead sponsor:** Instituto de Investigación Hospital Universitario La Paz
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-11-08
- **Primary completion:** 2024-12
- **Final completion:** 2024-12
- **Target enrollment:** 118 (ESTIMATED)
- **Last updated:** 2024-03-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04904653

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04904653, "The Effectiveness of Hemopatch® in the Reduction of Post-surgical Serous Drainage". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04904653. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
